Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 22234159)

1.

ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible.

Delatycki MB, Wolthuizen M, Collins V, Varley E, Craven J, Allen KJ, Gurrin LC, Aitken M, Trembath MK, Bond L, Wilson GR, Stephenson SE, Macciocca I, Hickerton C, Lockhart PJ, Metcalfe SA.

Eur J Hum Genet. 2012 May;20(5):505-9. doi: 10.1038/ejhg.2011.247. Epub 2012 Jan 11.

2.

Implementation of ironXS: a study of the acceptability and feasibility of genetic screening for hereditary hemochromatosis in high schools.

Delatycki MB, Wolthuizen M, Collins V, Varley E, Craven J, Allen KJ, Aitken MA, Bond L, Lockhart PJ, Wilson GR, Macciocca I, Metcalfe SA.

Clin Genet. 2010 Mar;77(3):241-8. doi: 10.1111/j.1399-0004.2009.01308.x. Epub 2009 Nov 23.

PMID:
19930418
3.

To tell or not to tell - what to do about p.C282Y heterozygotes identified by HFE screening.

Delatycki MB, Wolthuizen M, Aitken MA, Hickerton C, Metcalfe SA, Allen KJ.

Clin Genet. 2013 Sep;84(3):286-9. doi: 10.1111/cge.12053. Epub 2012 Nov 27.

PMID:
23121079
4.

Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?

Cadet E, Capron D, Gallet M, Omanga-Léké ML, Boutignon H, Julier C, Robson KJ, Rochette J.

J Med Genet. 2005 May;42(5):390-5.

5.

Asymptomatic individuals at genetic risk of haemochromatosis take appropriate steps to prevent disease related to iron overload.

Allen KJ, Nisselle AE, Collins VR, Williamson R, Delatycki MB.

Liver Int. 2008 Mar;28(3):363-9. doi: 10.1111/j.1478-3231.2008.01661.x.

PMID:
18290779
6.

Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.

McCune CA, Ravine D, Carter K, Jackson HA, Hutton D, Hedderich J, Krawczak M, Worwood M.

Gut. 2006 Apr;55(4):554-62. Epub 2005 Sep 20.

7.

[Molecular genetic diagnostics and screening of hereditary hemochromatosis].

Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S.

Vnitr Lek. 2006 Jun;52(6):602-8. Slovak.

PMID:
16871764
8.

The significance of haemochromatosis gene mutations in the general population: implications for screening.

Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA.

Gut. 1998 Dec;43(6):830-6.

9.

[Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].

Himmelmann A, Bortoluzzi L, Jansen S, Fehr J.

Schweiz Med Wochenschr. 2000 Aug 8;130(31-32):1112-9. German.

PMID:
11008304
10.

Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis.

Hickman PE, Hourigan LF, Powell LW, Cordingley F, Dimeski G, Ormiston B, Shaw J, Ferguson W, Johnson M, Ascough J, McDonell K, Pink A, Crawford DH.

Gut. 2000 Mar;46(3):405-9.

11.

Genotyping as a diagnostic aid in genetic haemochromatosis.

Rossi E, Henderson S, Chin CY, Olynyk J, Beilby JP, Reed WD, Jeffrey GP.

J Gastroenterol Hepatol. 1999 May;14(5):427-30.

PMID:
10355506
12.

Searching for hereditary hemochromatosis.

Laudicina RJ.

Clin Lab Sci. 2006 Summer;19(3):174-83.

PMID:
16910235
13.

Review article: haemochromatosis.

Whittington CA, Kowdley KV.

Aliment Pharmacol Ther. 2002 Dec;16(12):1963-75. Review.

14.

Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload.

Porto G, Cardoso CS, Gordeuk V, Cruz E, Fraga J, Areias J, Oliveira JC, Bravo F, Gangaidzo IT, MacPhail AP, Gomo ZA, Moyo VM, Melo G, Silva C, Justiça B, de Sousa M.

Eur J Haematol. 2001 Aug;67(2):110-8.

PMID:
11722599
15.

Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis.

Delatycki MB, Allen KJ, Nisselle AE, Collins V, Metcalfe S, du Sart D, Halliday J, Aitken MA, Macciocca I, Hill V, Wakefield A, Ritchie A, Gason AA, Nicoll AJ, Powell LW, Williamson R.

Lancet. 2005 Jul 23-29;366(9482):314-6.

PMID:
16039334
16.

Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.

Gottschalk R, Seidl C, Schilling S, Braner A, Seifried E, Hoelzer D, Kaltwasser JP.

Eur J Immunogenet. 2000 Jun;27(3):129-34.

PMID:
10940080
18.

Review article: targeted screening for hereditary haemochromatosis in high-risk groups.

DuBois S, Kowdley KV.

Aliment Pharmacol Ther. 2004 Jul 1;20(1):1-14. Review.

19.

Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods.

Milman N, Koefoed P, Pedersen P, Nielsen FC, Eiberg H.

Eur J Haematol. 2003 Dec;71(6):403-7.

PMID:
14703688
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk